Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial
2022 · The Lancet Oncology · 150 citations
https://doi.org/10.1016/s1470-2045(22)00613-1
E
Emilia J. Diego
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
126
Papers
1.5K
Citations
20
h-index
33
i10-index
Emilia J. Diego is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Breast Implant and Reconstruction. The author has an h-index of 20, co-authored 108 publications.
ORCID: 0000-0003-2155-817XPapers by this author
worksLow Estrogen Receptor (ER)–Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy
2018 · American Journal of Clinical Pathology · 76 citations
https://doi.org/10.1093/ajcp/aqy028
Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumors
2017 · Modern Pathology · 39 citations
https://doi.org/10.1038/modpathol.2017.41
The impact of Oncotype DX® recurrence score of paraffin-embedded core biopsy tissues in predicting response to neoadjuvant chemotherapy in women with breast cancer
2016 · Breast Disease · 38 citations
https://doi.org/10.3233/bd-150199
Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor–Positive Breast Cancer
2021 · JAMA Network Open · 33 citations
https://doi.org/10.1001/jamanetworkopen.2021.6322
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study
2024 · Journal of Clinical Oncology · 29 citations
https://doi.org/10.1200/jco.24.01052
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat